Ayala Pharmaceuticals Inc (ADXS)

[Meishairwin]

Oakroack, you asked this morning if there is a "standard" for stock option compensation? The amount of options for a CEO varies dramatically by size and development stage of a company. I can tell you that in Silicon Valley (where I spent 22 years and was CEO of companies) VCs typically consider giving non-founder CEO's something like 3%-5% of the company in a combo of RS/ options, heavily weighted to options.

I feel ADXS qualifies as a "venture" since it started with virtually zero capital. The CEO raised $200M+ without insider recapitalization, which suggests to me Dan would be given the high side of that 3%-5% spread.
Maybe FBG can tell us what % of ADXS Dan has in RS/ options so we can compare against this standard.